Working… Menu

A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy(REACH-DMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04587908
Recruitment Status : Recruiting
First Posted : October 14, 2020
Last Update Posted : February 9, 2021
Information provided by (Responsible Party):
Taiho Pharmaceutical Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2027
Estimated Study Completion Date : May 2027